Vibativ

Active Ingredient(s): Telavancin
FDA Approved: * September 11, 2009
Pharm Company: * THERAVANCE INC
Category: Antibiotics

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vibativ Overview

Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telavancin is a semi-synthetic derivative of vancomycin.[1][2] The FDA approved the drug in September 2009 for complicated skin and skin structure infections (cSSSI),[3] and in June 2013 for hospital-acquired and ventilator-associated bacterial pneumonia caused by Staphylococcus aureus.[4] Contents 1 History 2...

Read more Vibativ Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Telavancin

Recent Vibativ Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Vibativ: (6 results)

Sorted by National Drug Code

• 0469-3525 Vibativ 250 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
• 0469-3575 Vibativ 750 mg/1 Intravenous Injection, Powder, Lyophilized, for Solution by Astellas Pharma Us Inc.
• 52118-001 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
• 52118-002 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance, Inc.
• 62847-001 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.
• 62847-002 Vibativ 15 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Theravance Biopharma Antibiotics, Inc.

Other drugs which contain Telavancin or a similar ingredient: (1 result)

• TELAVANCIN